(Q50190209)

26 February 2018

title

Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology. (English)

1 reference

26 February 2018

0 references

1 reference

5

1 reference

26 February 2018

Aaron R. Folsom

3

object named as

Aaron R Folsom

1 reference

26 February 2018

Susan R Heckbert

4

object named as

Susan R Heckbert

1 reference

26 February 2018

Pamela L. Lutsey

2

object named as

Pamela L Lutsey

1 reference

26 February 2018

author name string

Neil A Zakai

1

1 reference

26 February 2018

publication date

29 April 2010

1 reference

26 February 2018

Thrombosis and Haemostasis

published in

1 reference

26 February 2018

volume

104

1 reference

26 February 2018

issue

2

1 reference

26 February 2018

page(s)

207-212

1 reference

26 February 2018

Activated partial thromboplastin time and risk of future venous thromboembolism

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

Fibrin fragment D-dimer and the risk of future venous thrombosis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

Analysis of the tissue factor pathway inhibitor gene and antigen levels in relation to venous thrombosis.

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

High levels of factor IX increase the risk of venous thrombosis

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

Tissue factor pathway inhibitor: a potent inhibitor of in-vitro coagulation and in-vivo thrombus formation

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

The Cardiovascular Health Study: design and rationale

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

22 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

14 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2943145

The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism--results from a randomized, double-blind, clinical trial

14 August 2018

1 reference

12 December 2020

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

1 reference

12 December 2020

Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and stroke

1 reference

12 December 2020

Short-term intraindividual variability in hemostasis factors. The ARIC Study. Atherosclerosis Risk in Communities Intraindividual Variability Study

1 reference

12 December 2020

Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis--a comparison with low molecular weight heparin

1 reference

12 December 2020

Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS)

1 reference

12 December 2020

Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis

1 reference

12 December 2020

Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism

1 reference

12 December 2020

Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state

1 reference

12 December 2020

Estimating interaction on an additive scale between continuous determinants in a logistic regression model

1 reference

12 December 2020

High levels of coagulation factor XI as a risk factor for venous thrombosis

1 reference

12 December 2020

Identifiers

DOI

10.1160/TH09-10-0693

1 reference

26 February 2018

PMC publication ID

2943145

1 reference

26 February 2018

PubMed publication ID

20431849

1 reference

26 February 2018